Alcântara, Pedro; Siqueira, Henrique; Shamim, Anwar 
; Priolli, Denise Gonçalves; Banagouro, Karine C. Q; Stefani, Hélio Alexandre ; Sciani, Juliana Mozer
Source: Drugs Drug Candidates. Unidade: FCF
Subjects: NEOPLASIAS PANCREÁTICAS, ADENOCARCINOMA, PRODUTOS NOVOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALCÂNTARA, Pedro et al. The role of a glucal-based molecule in the reduction of pancreatic adenocarcinoma an In vitro and In silico approach. Drugs Drug Candidates, v. 4, n. 2, p. 1-10 art. 21, 2025Tradução . . Disponível em: https://dx.doi.org/10.3390/ddc4020021. Acesso em: 22 jun. 2025.APA
Alcântara, P., Siqueira, H., Shamim, A., Priolli, D. G., Banagouro, K. C. Q., Stefani, H. A., & Sciani, J. M. (2025). The role of a glucal-based molecule in the reduction of pancreatic adenocarcinoma an In vitro and In silico approach. Drugs Drug Candidates, 4( 2), 1-10 art. 21. doi:10.3390/ddc4020021NLM
Alcântara P, Siqueira H, Shamim A, Priolli DG, Banagouro KCQ, Stefani HA, Sciani JM. The role of a glucal-based molecule in the reduction of pancreatic adenocarcinoma an In vitro and In silico approach [Internet]. Drugs Drug Candidates. 2025 ; 4( 2): 1-10 art. 21.[citado 2025 jun. 22 ] Available from: https://dx.doi.org/10.3390/ddc4020021Vancouver
Alcântara P, Siqueira H, Shamim A, Priolli DG, Banagouro KCQ, Stefani HA, Sciani JM. The role of a glucal-based molecule in the reduction of pancreatic adenocarcinoma an In vitro and In silico approach [Internet]. Drugs Drug Candidates. 2025 ; 4( 2): 1-10 art. 21.[citado 2025 jun. 22 ] Available from: https://dx.doi.org/10.3390/ddc4020021
